2022 Q1 Form 10-Q Financial Statement

#000165495422006448 Filed on May 11, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q4 2021 Q1

Balance Sheet

Concept 2022 Q1 2021 Q4 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $741.5K $372.6K $1.161M
YoY Change -36.15% 130.36% 254.81%
Cash & Equivalents $950.1K $575.3K $1.357M
Short-Term Investments
Other Short-Term Assets $258.4K $253.1K $227.9K
YoY Change 13.39% 8.86% -22.3%
Inventory
Prepaid Expenses
Receivables $89.59K $80.88K $143.4K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.090M $706.5K $1.533M
YoY Change -28.92% 39.05% 75.74%
LONG-TERM ASSETS
Property, Plant & Equipment $298.2K $342.4K $469.8K
YoY Change -36.54% -33.14% -28.81%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $298.2K $342.4K $469.8K
YoY Change -36.54% -33.14% -28.81%
TOTAL ASSETS
Total Short-Term Assets $1.090M $706.5K $1.533M
Total Long-Term Assets $298.2K $342.4K $469.8K
Total Assets $1.388M $1.049M $2.003M
YoY Change -30.7% 2.81% 30.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $115.2K $83.94K $143.8K
YoY Change -19.95% -46.14% -49.67%
Accrued Expenses $166.6K $167.2K $349.7K
YoY Change -52.35% -61.46% -69.53%
Deferred Revenue $464.2K
YoY Change -28.57%
Short-Term Debt $0.00 $5.000M $0.00
YoY Change 0.0% -100.0%
Long-Term Debt Due $5.000M $0.00 $0.00
YoY Change -100.0% -100.0%
Total Short-Term Liabilities $5.854M $5.872M $717.3K
YoY Change 716.21% 209.02% -98.62%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $5.542M
YoY Change -100.0% -100.0% 555.86%
Other Long-Term Liabilities $240.0K $282.5K $1.051M
YoY Change -77.16% -34.61% 75.14%
Total Long-Term Liabilities $240.0K $0.00 $6.593M
YoY Change -96.36% -100.0% 356.28%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.854M $5.872M $717.3K
Total Long-Term Liabilities $240.0K $0.00 $6.593M
Total Liabilities $6.094M $6.155M $7.310M
YoY Change -16.63% -26.93% -86.3%
SHAREHOLDERS EQUITY
Retained Earnings -$257.4M -$255.3M
YoY Change 5.86%
Common Stock $28.39K $28.39K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$4.707M -$5.106M -$5.307M
YoY Change
Total Liabilities & Shareholders Equity $1.388M $1.049M $2.003M
YoY Change -30.7% 2.81% 30.71%

Cashflow Statement

Concept 2022 Q1 2021 Q4 2021 Q1

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
28389493 shares
CY2022Q1 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
15000 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
0 USD
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
239992 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
282534 USD
CY2022Q1 us-gaap Liabilities
Liabilities
6094283 USD
CY2021Q4 us-gaap Liabilities
Liabilities
6154795 USD
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q1 most Designated For Series A Convertible Preferred Shares
DesignatedForSeriesAConvertiblePreferredShares
1750000 shares
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1497869 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1403276 shares
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
131459976 USD
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
127162277 USD
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28389493 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28389493 shares
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
28390 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
28390 USD
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
121235642 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
123015819 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-257430630 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-255312377 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-4706622 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-5105891 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1387661 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1048904 USD
CY2022Q1 most Subscription And Support Revenue
SubscriptionAndSupportRevenue
-329902 USD
CY2021Q1 most Subscription And Support Revenue
SubscriptionAndSupportRevenue
-417985 USD
CY2022Q1 us-gaap Revenues
Revenues
329902 USD
CY2021Q1 us-gaap Revenues
Revenues
417985 USD
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
123571 USD
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
205303 USD
CY2022Q1 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
0 USD
CY2021Q1 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
9000 USD
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
123571 USD
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
214303 USD
CY2022Q1 us-gaap Gross Profit
GrossProfit
206331 USD
CY2021Q1 us-gaap Gross Profit
GrossProfit
203682 USD
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
377883 USD
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
528294 USD
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1067196 USD
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
875666 USD
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
831934 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
905884 USD
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
2277013 USD
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
2309844 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2070682 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2106162 USD
CY2022Q1 us-gaap Interest Expense
InterestExpense
47571 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
142464 USD
CY2022Q1 most Gains Losses On Extinguishment Of Debt Other
GainsLossesOnExtinguishmentOfDebtOther
0 USD
CY2021Q1 most Gains Losses On Extinguishment Of Debt Other
GainsLossesOnExtinguishmentOfDebtOther
542100 USD
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-6507137 USD
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-47571 USD
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6107501 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2118253 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-8213663 USD
CY2022Q1 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
2597699 USD
CY2021Q1 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
0 USD
CY2022Q1 most Deemed Dividends Preferred Stock Stock
DeemedDividendsPreferredStockStock
-3464405 USD
CY2021Q1 most Deemed Dividends Preferred Stock Stock
DeemedDividendsPreferredStockStock
-5269401 USD
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8180357 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13483064 USD
CY2022Q1 most Basic And Fully Diluted From Continuing Operations
BasicAndFullyDilutedFromContinuingOperations
-0.29
CY2021Q1 most Basic And Fully Diluted From Continuing Operations
BasicAndFullyDilutedFromContinuingOperations
-0.47
CY2022Q1 most Basic And Fully Diluted
BasicAndFullyDiluted
28389493 shares
CY2021Q1 most Basic And Fully Diluted
BasicAndFullyDiluted
28389493 shares
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2118253 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-8213663 USD
CY2022Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
15000 USD
CY2021Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
2746 USD
CY2022Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 USD
CY2021Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
78120 USD
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
817522 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
886935 USD
CY2022Q1 most Gain Of Debt Extinguishment Ppp Loan Forgiveness
GainOfDebtExtinguishmentPppLoanForgiveness
0 USD
CY2021Q1 most Gain Of Debt Extinguishment Ppp Loan Forgiveness
GainOfDebtExtinguishmentPppLoanForgiveness
542100 USD
CY2022Q1 most Losses On Debt Extinguishments
LossesOnDebtExtinguishments
0 USD
CY2021Q1 most Losses On Debt Extinguishments
LossesOnDebtExtinguishments
-6507137 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
23719 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
32260 USD
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-458 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-11366 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
31211 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-12006 USD
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
11227 USD
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-50005 USD
CY2022Q1 most Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-44234 USD
CY2021Q1 most Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-42320 USD
CY2022Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-42542 USD
CY2021Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-39281 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
824 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2200 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1325270 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1297259 USD
CY2022Q1 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
0 USD
CY2021Q1 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
542000 USD
CY2022Q1 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
1700000 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
1761700 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1700000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2303700 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
374730 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1006441 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
575342 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
350923 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
950072 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1357364 USD
CY2022Q1 most Cash And Cash Equivalents
CashAndCashEquivalents
741497 USD
CY2021Q1 most Cash And Cash Equivalents
CashAndCashEquivalents
1161371 USD
CY2022Q1 most Restricteds Cash
RestrictedsCash
208575 USD
CY2021Q1 most Restricteds Cash
RestrictedsCash
195993 USD
CY2022Q1 most Total Cash Cash Equivalents And Restricted Cash
TotalCashCashEquivalentsAndRestrictedCash
950072 USD
CY2021Q1 most Total Cash Cash Equivalents And Restricted Cash
TotalCashCashEquivalentsAndRestrictedCash
1357364 USD
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
51788 USD
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
48150 USD
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
48125 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
48125 USD
CY2022Q1 most Recorded Discount Associated With Beneficial Conversion Feature On Issuance Of Series A Convertible Preferred Shares
RecordedDiscountAssociatedWithBeneficialConversionFeatureOnIssuanceOfSeriesAConvertiblePreferredShares
3464405 USD
CY2021Q1 most Recorded Discount Associated With Beneficial Conversion Feature On Issuance Of Series A Convertible Preferred Shares
RecordedDiscountAssociatedWithBeneficialConversionFeatureOnIssuanceOfSeriesAConvertiblePreferredShares
1761700 USD
CY2022Q1 most Issued Series A Preferred Shares Fair Valued At7660970 In Exchange For Carrying Value Of Debt Including Accrued Interest Premiums And Discounts Of1153833
IssuedSeriesAPreferredSharesFairValuedAt7660970InExchangeForCarryingValueOfDebtIncludingAccruedInterestPremiumsAndDiscountsOf1153833
0 USD
CY2021Q1 most Issued Series A Preferred Shares Fair Valued At7660970 In Exchange For Carrying Value Of Debt Including Accrued Interest Premiums And Discounts Of1153833
IssuedSeriesAPreferredSharesFairValuedAt7660970InExchangeForCarryingValueOfDebtIncludingAccruedInterestPremiumsAndDiscountsOf1153833
6507137 USD
CY2022Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
2597699 USD
CY2021Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
0 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-7403220 USD
CY2021Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
886935 USD
CY2021Q1 most Exchange Of Debt For Series A Convertible Preferred Shares On January282021 Amount
ExchangeOfDebtForSeriesAConvertiblePreferredSharesOnJanuary282021Amount
7660970 USD
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1761700 USD
CY2021Q1 most Beneficial Conversion Feature Recorded As A Result Of Issuance Of Series A Convertible Preferred Shares Of5269401
BeneficialConversionFeatureRecordedAsAResultOfIssuanceOfSeriesAConvertiblePreferredSharesOf5269401
5269401 USD
CY2021Q1 most Deemed Dividend To The Holders Of Series A Preferred Shares Resulting From Amortization Of Discount Associated With The Beneficial Conversion Feature
DeemedDividendToTheHoldersOfSeriesAPreferredSharesResultingFromAmortizationOfDiscountAssociatedWithTheBeneficialConversionFeature
-5269401 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-8213663 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-5307278 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-5105891 USD
CY2022Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
817522 USD
CY2022Q1 most Issuance Of Series A Convertible Preferred Shares For Cash Amount
IssuanceOfSeriesAConvertiblePreferredSharesForCashAmount
1700000 USD
CY2022Q1 most Stockissueddividend On Series A Convertible Preferred Shares Amount
StockissueddividendOnSeriesAConvertiblePreferredSharesAmount
0 USD
CY2022Q1 most Beneficial Conversion Feature Recorded As A Result Of Issuance Of Series A Convertible Preferred Shares Of5269401
BeneficialConversionFeatureRecordedAsAResultOfIssuanceOfSeriesAConvertiblePreferredSharesOf5269401
3464405 USD
CY2022Q1 most Deemed Dividend To The Holders Of Series A Preferred Shares Resulting From Amortization Of Discount Associated With The Beneficial Conversion Feature
DeemedDividendToTheHoldersOfSeriesAPreferredSharesResultingFromAmortizationOfDiscountAssociatedWithTheBeneficialConversionFeature
-3464405 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2118253 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-4706622 USD
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
7664728 USD
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P3Y1M6D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10883300 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.06
CY2021 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P7Y7M6D
CY2022Q1 most Aggregate Intrinsic Value Outstanding Beginning
AggregateIntrinsicValueOutstandingBeginning
9553832 USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
1382806 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
1.93
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
500000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.55
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10000494 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.11
CY2022Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P7Y7M6D
CY2022Q1 most Aggregate Intrinsic Value Outstanding Ending
AggregateIntrinsicValueOutstandingEnding
8946350 USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5415575 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
1.94
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y
CY2022Q1 most Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableIntrinsicValue
5718211 USD
CY2022Q1 most Closing Price Of The Common Stock
ClosingPriceOfTheCommonStock
3.00
CY2022Q1 most Fundamental Business Enterprise Value
FundamentalBusinessEnterpriseValue
39000000 USD
CY2022Q1 most Discount Rate On Trminal Value
DiscountRateOnTrminalValue
0.50 pure
CY2022Q1 most Number Of Shares Diluted
NumberOfSharesDiluted
72836053 shares
CY2022Q1 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
1481552 shares
CY2022Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
279898 USD
CY2022Q1 us-gaap Revenues
Revenues
329902 USD
CY2021Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
429211 USD
CY2021Q1 us-gaap Revenues
Revenues
417985 USD
CY2021Q1 us-gaap Revenues
Revenues
417985 USD
CY2022Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
279898 USD
CY2022Q1 us-gaap Revenues
Revenues
329902 USD
CY2021Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
429211 USD
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
51788 USD
CY2022Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P2Y29D
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.08 pure
CY2022Q1 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
153878 USD
CY2022Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
205593 USD
CY2022Q1 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
68531 USD
CY2022Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
428002 USD
CY2022Q1 most Imputed Interest
ImputedInterest
-38485 USD
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
389517 USD
CY2022Q1 most Series A Preferred Stock Issued
SeriesAPreferredStockIssued
11655 shares
CY2022Q1 most Cash Proceeds From Issuance Of Series A Preferred Stock
CashProceedsFromIssuanceOfSeriesAPreferredStock
500000 USD

Files In Submission

Name View Source Status
0001654954-22-006448-index-headers.html Edgar Link pending
0001654954-22-006448-index.html Edgar Link pending
0001654954-22-006448.txt Edgar Link pending
0001654954-22-006448-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
most-20220331.xsd Edgar Link pending
most-20220331_cal.xml Edgar Link unprocessable
most-20220331_def.xml Edgar Link unprocessable
most-20220331_lab.xml Edgar Link unprocessable
most-20220331_pre.xml Edgar Link unprocessable
most_10q.htm Edgar Link pending
most_10q_htm.xml Edgar Link completed
most_ex311.htm Edgar Link pending
most_ex312.htm Edgar Link pending
most_ex321.htm Edgar Link pending
most_ex322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending